IDEXX Laboratories Inc
(FRA:IX1)
€
473.8
-0.90 (-0.19%)
Market Cap: 38.07 Bil
Enterprise Value: 38.87 Bil
PE Ratio: 40.44
PB Ratio: 27.96
GF Score: 96/100 IDEXX Laboratories Inc at Stifel Jaws & Paws Conference Transcript
May 27, 2026 / 02:55PM GMT
Release Date Price:
€477.4
(-0.93%)
Jonathan Block
Stifel Nicolaus & Company Inc - Analyst
It's Jon Block with Stifel. Good to see everyone. We're going to push forward. And next up on stage, we have IDEXX Laboratories, the leader in animal health diagnostics and joining me on the stage is the company's relatively new President and CEO, Mike Erickson; as well as John Ravis, Vice President of IR. Guys, thanks very much for joining Jaws & Paws again.
Mike Erickson
IDEXX Laboratories Inc - President, Chief Executive Officer
Thanks for having us, Jon.
Questions & Answers
Jonathan Block
Stifel Nicolaus & Company Inc - Analyst
Mike, I got sort of the typical tee-up question, 30 days on the job, give or take, but you have been at IDEXX for 15 years roughly. So just walk us through maybe those top two or three goals that you see for the company that you're looking to implement going forward?
Mike Erickson
IDEXX Laboratories Inc - President, Chief Executive Officer
Well, first off, huge,
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |

30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot